Daniel Charles Bowers, MD $$

Pediatric Hematologist/Oncologist

Professor Scholar at UT Southwestern Medical Center

Languages Spoken:
English

Locations

Virtual Visit Available

UT Southwestern Pediatric Group

Request an Appointment

Refer a Patient

Biography

Daniel Bowers, M.D., is the medical director of pediatric neuro-oncology at Children’s Health. He is also a professor of pediatrics and neurological surgery at UT Southwestern Medical Center. 

Dr. Bowers earned his medical degree at UT Southwestern. He then completed his residency in general pediatrics at UT Southwestern and performed his fellowship in pediatric hematology and oncology at the Johns Hopkins University School of Medicine. 

Dr. Bowers is a full member of the Children’s Oncology Group and serves on the central nervous system tumors committee, where his role is to develop new treatments for low-grade gliomas in children. He soon will be leading a national clinical trial for children with recurrent low-grade gliomas.

We offer the most advanced treatment that can be found anywhere in the world for a child with a brain tumor.
Daniel Bowers, MD

Dr. Bowers cares for children with brain tumors along with other members of the pediatric brain tumor multidisciplinary team, including pediatric neurosurgeons, radiation oncologists, pediatric neurologists, neuro-radiologists and neuro-pathologists.

He strongly believes in the care his team provides. “We offer the most advanced treatment that can be found anywhere in the world for a child with a brain tumor,” says Dr. Bowers. “Our outstanding group of doctors is unmatched. You can get it all right here.”

In addition to his clinical care of children with brain tumors, Dr. Bowers leads the After the Cancer Experience program at Children’s Health, a childhood cancer survivorship program that monitors survivors of childhood cancer for long-term effects they may have from their cancer treatment or the cancer itself.

"As more children survive their cancer diagnosis, we know that about two-thirds of them have some long-term complication and about one-third will have what is considered a severe or life-threatening complication," Dr. Bowers says. “When we monitor these children as they grow, we can intervene if something starts to change or go wrong and help them through it.” 

Dr. Dan Bower (hematology/oncology) with patient Sydney - Children's Health

Dr. Bowers is well known nationally for his understanding of the long-term side effects seen among childhood brain tumor survivors. He has been recognized by D Magazine as a Best Doctor in the category of Best Pediatric Specialist: Oncology/Hematology and as a favorite oncology professional by CureSearch for Children’s Cancer.

Dr. Bowers serves on the advisory committee on childhood cancers for the Cancer Prevention and Research Institute of Texas and as a member of the board of directors of the Clayton Dabney Foundation. He also is a member of the American Society of Clinical Oncology, the Society for Neuro-Oncology, the American Society of Pediatric Hematology/Oncology and the Society for Pediatric Research.

Education and Training

Medical School
University of Texas Southwestern Medical Center (1993)
Internship
Children's Medical Center Dallas (1994), Pediatrics
Residency
Children's Medical Center Dallas (1996), Pediatrics
Fellowship
John Hopkins Hospital (1999), Pediatric Hematology/Oncology
Board Certification
American Board of Pediatrics/Hematology-Oncology
  • Research Interests

    • Evaluation of quality of life and late effects of childhood cancer survivors
    • New therapies for childhood brain tumors
  • Publications

    Publications

    • Radiation, Atherosclerotic Risk Factors and Stroke Risk in Young Adult Survivors of Pediatric Cancer: Report from the Childhood Cancer Survivor Study. Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR. International Journal of Radiation Oncology, Biology, Physics, 2013; 86:649-55.
    • Genomic Analysis of Diffuse Pediatric Low-Grade Gliomas Identifies Recurrent, Oncogenic MYBL1-Truncating Rearrangements. Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence M, Bergthold G, Brastianos PL, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, Cho Y-J, Taha H, Mahmoud M, Bowers DC, Margraf L, Tabori U, Hawkins C, Packer RJ, Ashley Hill D, Pomeroy SL, Eberhart CG, Dunn IF, Goumnerova L, Getz G, Chan JA, Santagata S, Hahn WC, Stiles CD, Ligon AH, Kieran MW, Beroukhim R, Ligon KL. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110:8188-93.
    • Subsequent Neoplasms of the Central Nervous System among Survivors of Childhood Cancer: A Systematic Review: A Report from the Second Malignant Neoplasm Task Force of the Survivorship and Outcomes Committee of the Children’s Oncology Group. Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, Bashore L. Lancet Oncology, 2013; 14:e321–28.

    Books

    • Strokes Among Childhood Brain Tumor Survivors. In Goldman S, Turner CD, eds. Late Effects of Treatment for Brain Tumors. Bowers DC. (2009). Springer; 145-153.
  • Professional Activities

    • American Society of Clinical Oncology (1999-2023)
    • Children's Oncology Group (1999-2023)
    • Society for Neuro-Oncology (2000-2023)
    • Society for Pediatric Research (2006-2023)
  • Awards and Honors

    • Favorite Oncology Professionals - CureSearch for Children’s Cancer (2013-2013)
    • Best Pediatric Specialists/Doctors in Dallas - D Magazine (2010-2021)
    • Elected to the Society for Pediatric Research (2006-2023)
    • Outstanding Graduate in the College of Science, Texas A&M University (1989-1989)

Virtual Visit

This provider may offer virtual appointments. Please review our Virtual Visit Specialty Clinics page for instructions on setting up a visit.

Where I Provide Care: